within Pharmacolibrary.Drugs.ATC.N;

model N02CC08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 0.0009750000000000001,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.194,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0062,
    Tlag           = 18.6
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N02CC08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Lasmiditan is a selective serotonin 5-HT1F receptor agonist used for the acute treatment of migraine with or without aura in adults. It is approved for use in several countries, including the United States.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic data following single oral administration in healthy adult volunteers, both male and female.</p><h4>References</h4><ol><li><p>Tsai, M, et al., &amp; Wilbraham, D (2020). Effects of Lasmiditan on Cardiovascular Parameters and Pharmacokinetics in Healthy Subjects Receiving Oral Doses of Propranolol. <i>Clinical pharmacology in drug development</i> 9(5) 629–638. DOI:<a href=\"https://doi.org/10.1002/cpdd.768\">10.1002/cpdd.768</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31950732/\">https://pubmed.ncbi.nlm.nih.gov/31950732</a></p></li><li><p>Tsai, M, et al., &amp; Winner, P (2021). Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine. <i>Clinical pharmacokinetics</i> 60(6) 819–828. DOI:<a href=\"https://doi.org/10.1007/s40262-020-00966-z\">10.1007/s40262-020-00966-z</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33565026/\">https://pubmed.ncbi.nlm.nih.gov/33565026</a></p></li><li><p>Pergolizzi, JV, et al., &amp; Varrassi, G (2024). An update on pharmacotherapy for trigeminal neuralgia. <i>Expert review of neurotherapeutics</i> 24(8) 773–786. DOI:<a href=\"https://doi.org/10.1080/14737175.2024.2365946\">10.1080/14737175.2024.2365946</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38870050/\">https://pubmed.ncbi.nlm.nih.gov/38870050</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N02CC08;
